Bristol Myers Squibb’s Alzheimer’s Drug, BMS-986446, Granted FDA Fast Track Status

新聞報導於大約8小時前

撰寫摘要中...

您可能也對這些小見聞有興趣

中國市場重啟：AI熱潮能否蓋過疲弱消費

對沖基金押注年底美元上漲，選擇權交易增長

Brace yourself for some unpleasant Medicare drug changes next year. Here's how to ease the pain.

美國批准部分Nvidia向阿聯酋銷售，特朗普推動人工智慧外交

Fed's Williams backs more rate cuts this year due to labor market slowdown risks, he tells NYT

Exclusive: Mentium raises $3.2 million to bring modern technology to freight brokerages

台積電預測超越第三季營收因人工智慧蓬勃發展

You can live healthy to 100, author says, Here's the secret.

油價因加沙和平計劃與美國庫存影響而波動

Here's What to Expect From Amgen’s Next Earnings Report

返回所有小見聞